nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms
|
Wang, Xiaoyi |
|
|
28 |
5 |
p. |
artikel |
2 |
Association between klotho and non-alcoholic fatty liver disease and liver fibrosis based on the NHANES 2007–2016
|
Chi, Zhenfei |
|
|
28 |
5 |
p. |
artikel |
3 |
Circular RNA hsa_circ_0098181 inhibits metastasis in hepatocellular carcinoma by activating the Hippo signaling pathway via interaction with eEF2
|
Gao, Ping |
|
|
28 |
5 |
p. |
artikel |
4 |
CSNK2A2 promotes hepatocellular carcinoma progression through activation of NF-κB pathway
|
Yang, Shuang |
|
|
28 |
5 |
p. |
artikel |
5 |
Editorial board
|
|
|
|
28 |
5 |
p. |
artikel |
6 |
Effect of acute on chronic liver failure over post-transplant survival
|
Benítez, Carlos |
|
|
28 |
5 |
p. |
artikel |
7 |
Examining genetic associations with hepatic steatosis in Mexican-origin adults
|
Trejo, Mario Jesus |
|
|
28 |
5 |
p. |
artikel |
8 |
Gut dysbiosis in alcoholic liver disease: Wonderful dilemma?
|
Abenavoli, Ludovico |
|
|
28 |
5 |
p. |
artikel |
9 |
IL-18 discriminates highly frequent hepatitis E virus positive from negative blood donors in Mexico
|
Copado-Villagrana, Edgar D. |
|
|
28 |
5 |
p. |
artikel |
10 |
Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir
|
Da Wang, Fa- |
|
|
28 |
5 |
p. |
artikel |
11 |
Nonalcoholic fatty liver disease: A risk factor for chronic kidney disease
|
Carvalho, Kellyane Dias |
|
|
28 |
5 |
p. |
artikel |
12 |
Racial, ethnic, and socioeconomic disparities impact post-liver transplant survival in patients with hepatocellular carcinoma
|
Huang, Dora C. |
|
|
28 |
5 |
p. |
artikel |
13 |
Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older
|
Mujtaba, Muhammad A. |
|
|
28 |
5 |
p. |
artikel |